Evidence map›Paper›PMID 36555426›Full record

ArticleInternational journal of molecular sciences2022

Transcription Factors STAT3 and MYC Are Key Players of Human Platelet Lysate-Induced Cell Proliferation.

Michaela Oeller, Heidi Jaksch-Bogensperger, Markus Templin, Renate Gehwolf, Eva Rohde, Katharina Schallmoser, Sandra Laner-Plamberger

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Sialylation-immune-related lncRNAFrontiers in immunology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Michaela OellerDepartment of Transfusion Medicine, Salzburger Landeskliniken (SALK) & Paracelsus Medical University Salzburg (PMU), 5020 Salzburg, Austria.
Heidi Jaksch-BogenspergerDepartment of Obstetrics and Gynaecology, Salzburger Landeskliniken (SALK) & Paracelsus Medical University Salzburg (PMU), 5020 Salzburg, Austria.
Markus TemplinNMI Natural and Medical Sciences Institute at the University of Tuebingen, 72770 Reutlingen, Germany.ORCID 0000-0002-6569-6489
Renate GehwolfSpinal Cord Injury and Tissue Regeneration Center Salzburg, PMU Salzburg, 5020 Salzburg, Austria.
Eva RohdeDepartment of Transfusion Medicine, Salzburger Landeskliniken (SALK) & Paracelsus Medical University Salzburg (PMU), 5020 Salzburg, Austria.ORCID 0000-0001-8692-886X
Katharina SchallmoserDepartment of Transfusion Medicine, Salzburger Landeskliniken (SALK) & Paracelsus Medical University Salzburg (PMU), 5020 Salzburg, Austria.ORCID 0000-0002-7204-0058
Sandra Laner-PlambergerDepartment of Transfusion Medicine, Salzburger Landeskliniken (SALK) & Paracelsus Medical University Salzburg (PMU), 5020 Salzburg, Austria.ORCID 0000-0002-1416-6023
Paracelsus Medical University · ATNatural and Medical Sciences Institute · DEUniversity of Salzburg · AT

Funding

Paracelsus Medical University Salzburg (Forschungsförderungsfond, PMU-FFF) R2004137-PLS
6 · The paper itself

Abstract

Human platelet lysate (HPL) is an efficient alternative for animal serum supplements, significantly enhancing stromal cell proliferation. However, the molecular mechanism behind this growth-promoting effect remains elusive. The aim of this study was to investigate the effect of HPL on cell cycle gene expression in different human stromal cells and to identify the main key players that mediate HPL's growth-enhancing effect. RT-qPCR and an antibody array revealed significant upregulation of cell cycle genes in stromal cells cultured in HPL. As HPL is rich in growth factors that are ligands of tyrosine kinase receptor (TKR) pathways, we used TKR inhibitors and could significantly reduce cell proliferation. Genome profiling, RT-qPCR and Western blotting revealed an enhanced expression of the transcription factors signal transducer and activator of transcription 3 (STAT3) and MYC, both known TKR downstream effectors and stimulators of cell proliferation, in response to HPL. In addition, specifically blocking STAT3 resulted in reduced cell proliferation and expression of cell cycle genes. Our data indicate that HPL-enhanced cell proliferation can, at least in part, be explained by the TKR-enhanced expression of STAT3 and MYC, which in turn induce the expression of genes being involved in the promotion and control of the cell cycle.

Indexed as

Mesenchymal Stem CellsProto-Oncogene Proteins c-mycSTAT3 Transcription FactorAnimalsBlood PlateletsCell Culture TechniquesCell DifferentiationCell ProliferationCells, CulturedHumansStromal CellsMYC protein, humanProto-Oncogene Proteins c-mycSTAT3 protein, humanSTAT3 Transcription Factorhuman mesenchymal stromal cells (MSCs)human platelet lysate (HPL)MYCproliferationsignal transducer and activator of transcription 3 (STAT3)

Identifiers

PMID36555426
PMCPMC9781157
OpenAlexW4311230965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.